A study tracking women for more than two decades adds to growing evidence that when menopause hormone therapy is started may influence dementia risk later in life.

Real-world data from more than 137,000 women shows early HRT significantly improves long term bone health ...

Several contemporary formulations of hormone therapy administered during the menopausal transition carry some degree of cardiovascular risk, Swedish registry data affirm. Most consistent was an ...

For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration describing the medication’s risk of serious harms – namely, cancer, ...

With the removal of FDA warning labels, hormone therapy to treat symptoms of menopause has grown in popularity. Now some patients are reporting delays in filling prescriptions for estrogen patches.

The warning label placed on all estrogen-based treatments since 2003 was based on an outdated and flawed government-funded ...

Menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is not associated with an increased risk of death, finds a Danish study of over 800,000 women published in The BMJ.

Breast cancer risk screening using biomarkers and oestrogen metabolism markers could help predict individual risk before starting HRT.

Women who start hormone replacement therapy (HRT) within a year after menopause may have a lower risk of developing osteoporosis, according to research presented at the American Academy of Orthopaedic ...

Hormone therapies for menopause will no longer carry a black box warning about serious risks such as breast cancer, heart attack and stroke, the Food and Drug Administration announced Monday. In the ...

Menopause has long been a hush-hush topic, something on the periphery of our minds that no one really wants to talk about. (Except maybe in hushed whispers with your best friend while fanning yourself ...